Letters in Drug Design & Discovery
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 8
Author(s): Dominique Heymann
Affiliation:
Export Options
About this article
Cite this article as:
Heymann Dominique, Meet Our Editorial Board Member , Letters in Drug Design & Discovery 2019; 16 (8) . https://dx.doi.org/10.2174/157018081608190712100045
DOI https://dx.doi.org/10.2174/157018081608190712100045 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]
Current Cancer Drug Targets Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Cancer Electrogene Therapy with Interleukin-12
Current Gene Therapy How (and Why) to Revive a Dead Enzyme: The Power of Chemical Rescue
Current Chemical Biology Chemistry and Biology of Fascaplysin, a Potent Marine-Derived CDK-4 Inhibitor
Mini-Reviews in Medicinal Chemistry HIV-1 Integrase: From Biology to Chemotherapeutics
Current HIV Research Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors
Current Topics in Medicinal Chemistry Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy Thiazole, Isatin and Phthalimide Derivatives Tested <i>in vivo</i> against Cancer Models: A Literature Review of the Last Six Years
Current Medicinal Chemistry Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived Compounds
Current Pharmaceutical Design Targeted Cancer Stem Cell Therapeutics: An Update
Current Topics in Medicinal Chemistry Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives
Current Biotechnology The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer
Anti-Cancer Agents in Medicinal Chemistry Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Current Stem Cell Research & Therapy